Animal transgenic and knockout models have demonstrated that it is able to cleave structural proteins leading to tissue remodelling (as discussed within ‘Pathophysiological functions of PR3 in COPD’), through diffusing deeper into tissues than the other NSPs [27–30]. Here, PRTN3 is linked to chronic obstructive pulmonary disease.